But this time around, the deal seems more concrete
In May 2026, At the EASL Congress 2026, MetaVia presented promising late-breaking Phase 1 clinical trial results for DA-1726, an investigational dual GLP-1 and glucagon receptor agonist under development for obesity and Metabolic Dysfunction-Associated Steatohepatitis (MASH)
There was a slightly higher rate of gallbladder disorders in the semaglutide vs
Tirzepatide activates both GLP-1 and GIP receptors, providing dual mechanisms for appetite suppression and metabolic regulation
Olimp L-Carnitine + Caffeine Extreme Shot is a cherry-flavoured liquid dietary supplement (25 ml ampoule) containing L-carnitine (2000 mg), caffeine (125 mg) and vitamin B6 (1.4 mg, 100% RDA)
However, most people see noticeable improvements after 3 to 6 IV Drip sessions